deltatrials
Active Not Recruiting NCT00039676

Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer

Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Blood and Lymph Node Malignancy

Sponsor: National Cancer Institute (NCI)

Conditions Chronic Lymphocytic Leukemia Hodgkin Disease Mixed Lymphoproliferative Disease NonHodgkin Lymphoma Waldenstrom Macroglobulinemia
Updated 82 times since 2017 Last updated: Mar 5, 2026 Started: Jul 8, 2002

A observational or N/A phase clinical study on Chronic Lymphocytic Leukemia and Hodgkin Disease, this trial is ongoing. The trial is conducted by National Cancer Institute (NCI) and has accumulated 82 data snapshots since 2002. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Change History

82 versions recorded

  1. Mar 2026 — Present [monthly]

    Active Not Recruiting

  2. Feb 2026 — Mar 2026 [monthly]

    Active Not Recruiting

  3. Jan 2026 — Feb 2026 [monthly]

    Active Not Recruiting

  4. Dec 2025 — Jan 2026 [monthly]

    Active Not Recruiting

  5. Nov 2025 — Dec 2025 [monthly]

    Active Not Recruiting

▶ Show 77 earlier versions

  1. Oct 2025 — Nov 2025 [monthly]

    Active Not Recruiting

  2. Sep 2025 — Oct 2025 [monthly]

    Active Not Recruiting

  3. Aug 2025 — Sep 2025 [monthly]

    Active Not Recruiting

  4. Jul 2025 — Aug 2025 [monthly]

    Active Not Recruiting

  5. Jun 2025 — Jul 2025 [monthly]

    Active Not Recruiting

  6. May 2025 — Jun 2025 [monthly]

    Active Not Recruiting

  7. Apr 2025 — May 2025 [monthly]

    Active Not Recruiting

  8. Mar 2025 — Apr 2025 [monthly]

    Active Not Recruiting

  9. Feb 2025 — Mar 2025 [monthly]

    Active Not Recruiting

  10. Jan 2025 — Feb 2025 [monthly]

    Active Not Recruiting

  11. Dec 2024 — Jan 2025 [monthly]

    Active Not Recruiting

  12. Nov 2024 — Dec 2024 [monthly]

    Active Not Recruiting

  13. Oct 2024 — Nov 2024 [monthly]

    Active Not Recruiting

  14. Sep 2024 — Oct 2024 [monthly]

    Active Not Recruiting

  15. Aug 2024 — Sep 2024 [monthly]

    Active Not Recruiting

  16. Jul 2024 — Aug 2024 [monthly]

    Active Not Recruiting

  17. Jun 2024 — Jul 2024 [monthly]

    Active Not Recruiting

  18. May 2024 — Jun 2024 [monthly]

    Active Not Recruiting

  19. Apr 2024 — May 2024 [monthly]

    Active Not Recruiting

  20. Mar 2024 — Apr 2024 [monthly]

    Active Not Recruiting

  21. Feb 2024 — Mar 2024 [monthly]

    Active Not Recruiting

  22. Jan 2024 — Feb 2024 [monthly]

    Active Not Recruiting

    Status: Recruiting → Active Not Recruiting

  23. Dec 2023 — Jan 2024 [monthly]

    Recruiting

  24. Nov 2023 — Dec 2023 [monthly]

    Recruiting

  25. Oct 2023 — Nov 2023 [monthly]

    Recruiting

  26. Sep 2023 — Oct 2023 [monthly]

    Recruiting

  27. Aug 2023 — Sep 2023 [monthly]

    Recruiting

  28. Jul 2023 — Aug 2023 [monthly]

    Recruiting

  29. Jun 2023 — Jul 2023 [monthly]

    Recruiting

  30. May 2023 — Jun 2023 [monthly]

    Recruiting

  31. Apr 2023 — May 2023 [monthly]

    Recruiting

  32. Mar 2023 — Apr 2023 [monthly]

    Recruiting

  33. Feb 2023 — Mar 2023 [monthly]

    Recruiting

  34. Jan 2023 — Feb 2023 [monthly]

    Recruiting

  35. Dec 2022 — Jan 2023 [monthly]

    Recruiting

  36. Nov 2022 — Dec 2022 [monthly]

    Recruiting

  37. Sep 2022 — Nov 2022 [monthly]

    Recruiting

  38. Jul 2022 — Sep 2022 [monthly]

    Recruiting

  39. Jun 2022 — Jul 2022 [monthly]

    Recruiting

  40. May 2022 — Jun 2022 [monthly]

    Recruiting

  41. Apr 2022 — May 2022 [monthly]

    Recruiting

  42. Mar 2022 — Apr 2022 [monthly]

    Recruiting

  43. Feb 2022 — Mar 2022 [monthly]

    Recruiting

  44. Jan 2022 — Feb 2022 [monthly]

    Recruiting

  45. Nov 2021 — Jan 2022 [monthly]

    Recruiting

  46. Oct 2021 — Nov 2021 [monthly]

    Recruiting

  47. Sep 2021 — Oct 2021 [monthly]

    Recruiting

  48. Jun 2021 — Sep 2021 [monthly]

    Recruiting

  49. May 2021 — Jun 2021 [monthly]

    Recruiting

  50. Apr 2021 — May 2021 [monthly]

    Recruiting

  51. Mar 2021 — Apr 2021 [monthly]

    Recruiting

  52. Feb 2021 — Mar 2021 [monthly]

    Recruiting

  53. Jan 2021 — Feb 2021 [monthly]

    Recruiting

  54. Dec 2020 — Jan 2021 [monthly]

    Recruiting

  55. Nov 2020 — Dec 2020 [monthly]

    Recruiting

  56. Oct 2020 — Nov 2020 [monthly]

    Recruiting

  57. Sep 2020 — Oct 2020 [monthly]

    Recruiting

  58. Aug 2020 — Sep 2020 [monthly]

    Recruiting

  59. Jul 2020 — Aug 2020 [monthly]

    Recruiting

  60. Jun 2020 — Jul 2020 [monthly]

    Recruiting

  61. May 2020 — Jun 2020 [monthly]

    Recruiting

  62. Apr 2020 — May 2020 [monthly]

    Recruiting

  63. Mar 2020 — Apr 2020 [monthly]

    Recruiting

  64. Feb 2020 — Mar 2020 [monthly]

    Recruiting

  65. Jan 2020 — Feb 2020 [monthly]

    Recruiting

  66. Dec 2019 — Jan 2020 [monthly]

    Recruiting

  67. Oct 2019 — Dec 2019 [monthly]

    Recruiting

  68. Jun 2019 — Oct 2019 [monthly]

    Recruiting

  69. May 2019 — Jun 2019 [monthly]

    Recruiting

  70. Mar 2019 — May 2019 [monthly]

    Recruiting

  71. Feb 2019 — Mar 2019 [monthly]

    Recruiting

  72. Sep 2018 — Feb 2019 [monthly]

    Recruiting

  73. Aug 2018 — Sep 2018 [monthly]

    Recruiting

  74. Jul 2018 — Aug 2018 [monthly]

    Recruiting

  75. Jun 2018 — Jul 2018 [monthly]

    Recruiting

  76. Apr 2018 — Jun 2018 [monthly]

    Recruiting

    Phase: NA → None

  77. Jan 2017 — Apr 2018 [monthly]

    Recruiting NA

    First recorded

Jul 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Cancer Institute (NCI)
Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Bethesda, United States
  • • Rockville, United States